The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: A cross-sectional and longitudinal study

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Sandoo, Aamer ^a,b   Protogerou, Athanassios D ^c   Hodson, James ^d   Smith, Jacqueline P ^a   Zampeli, Evi ^c   Sfikakis, Petros P ^c   Kitas, George D ^a,b,e  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ANTIHYPERTENSIVE AGENT; ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; AUGMENTATION INDEX; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; RHEUMATOID ARTHRITIS; SUBENDOCARDIAL VIABILITY RATIO; AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ENDOCARDIUM; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTONOMIC NERVOUS SYSTEM; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ENDOCARDIUM; FEMALE; HEART RATE; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84870064697     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4103     Document Type: Article

References (49)

1. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 2003, 42:607-613.
2. Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2011, 70:8-14. 10.1136/ard.2010.142133, 21109513.
3. Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med 2005, 7:1-24.
4. Levy L, Fautrel B, Barnetche T, Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 2008, 26:673-679.
5. Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, Lima JA, Kobayashi H. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 2010, 12:R171. 10.1186/ar3131, 2990998, 20836862.
6. Toutouzas K, Sfikakis PP, karanasos A, Aggeli C, Felekos I, Kitas G, Zampeli E, Protogerou A, Stefanadis C. Myocardial ischemia without obstructive coronary artery disease in rheumatoid arthritis. Hypothesis-generating insights from a cross-sectional study. Rheumatology 2013, 52:76-80. 10.1093/rheumatology/kes349, 23185038.
7. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003, 23:554-566. 10.1161/01.ATV.0000060460.52916.D6, 12615661.
8. Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C. Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation 1995, 92:342-347. 10.1161/01.CIR.92.3.342, 7634447.
9. Sarnoff SJ, Braunwald E, Welch GH, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to tension-time index. Am J Physiol 1958, 192:148-156.
10. Buckberg GD, Fixler DE, Archie JP, Hoffman JIE. Experimental subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1972, 65:664-685.
11. Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, Toutouzas K, Tsiamis E, Stefanadis C. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens 2012, 26:64-70. 10.1038/jhh.2010.127, 21228823.
12. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ. Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes. Atherosclerosis 2010, 213:469-474. 10.1016/j.atherosclerosis.2010.08.080, 2997940, 20880527.
13. Secrest AM, Marshall SL, Miller RG, Prince CT, Orchard TJ. Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Technol Ther 2011, 13:1264-1268. 10.1089/dia.2011.0126, 3263305, 21819228.
14. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ. Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes. Diab Vasc Dis Res 2010, 7:216-224. 10.1177/1479164110375297, 3047589, 20605853.
15. Turzyniecka M, Wild SH, Krentz AJ, Chipperfield AJ, Clough GF, Byrne CD. Diastolic function is strongly and independently associated with cardiorespiratory fitness in central obesity. J Appl Physiol 2010, 108:1568-1574. 10.1152/japplphysiol.00023.2010, 20339006.
16. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ. Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care 2010, 33:652-657. 10.2337/dc09-1936, 2827525, 20040653.
17. Tam LS, Li EK, Shang Q, Tomlinson B, Lee VW, Lee KK, Li M, Kuan WP, Li TK, Tseung L, Yip GW, Freedman B, Yu CM. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial. Scand J Rheumatol 2011, 40:411-421. 10.3109/03009742.2011.586649, 21867445.
18. Pieringer H, Stuby U, Pohanka E, Biesenbach G. Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab. Clin Rheumatol 2010, 29:723-727. 10.1007/s10067-010-1388-4, 20162315.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
20. Prevoo ML, Van 't Hof MA, Kuper HH, Van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
21. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986, 25:206-209. 10.1093/rheumatology/25.2.206, 3708236.
22. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402-411. 10.1002/art.20853, 15693010.
23. George KP, Naylor LH, Whyte GP, Shave RE, Oxborough D, Green DJ. Diastolic function in healthy humans: non-invasive assessment and the impact of acute and chronic exercise. Eur J Appl Physiol 2010, 108:1-14.
24. Protogerou AD, Safar ME, Iaria P, Safar H, Le DK, Filipovsky J, Henry O, Ducimetiere P, Blacher J. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007, 50:172-180. 10.1161/HYPERTENSIONAHA.107.089797, 17515449.
25. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003, 108:2957-2963. 10.1161/01.CIR.0000099844.31524.05, 14676136.
26. Peters MJL, Symmons DPM, McCarey D, Dijkmans BAC, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69:325-331. 10.1136/ard.2009.113696, 19773290.
27. Holmqvist ME, Wedren S, Jacobsson LT, Klareskog L, Nyberg F, Rantapaa-Dahlqvist S, Alfredsson L, Askling J. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 2010, 268:578-585. 10.1111/j.1365-2796.2010.02260.x, 20698926.
28. Franklin J, Farragher TM, Lunt M, Camacho EM, Bunn D, Marshall T, Symmons DP. Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis. Ann Rheum Dis 2010, 69:1660-1664. 10.1136/ard.2009.121871, 2938882, 20498206.
29. Pingiotti E, Cipriani P, Marrelli A, Liakouli V, Fratini S, Penco M, Giacomelli R. Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage. Ann N Y Acad Sci 2007, 1107:32-41. 10.1196/annals.1381.004, 17804530.
30. Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 2003, 48:72-80. 10.1002/art.10735, 12528106.
31. Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004, 63:31-35. 10.1136/ard.2003.007740, 1754717, 14672888.
32. Hannawi S, Haluska B, Marwick TH, Thomas R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 2007, 9:R116. 10.1186/ar2323, 2246234, 17986352.
33. Sodergren A, Karp K, Boman K, Eriksson C, Lundstrom E, Smedby T, Soderlund L, Rantapaa-Dahlqvist S, Wallberg-Jonsson S. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther 2010, 12:R158. 10.1186/ar3116, 2945061, 20712865.
34. Del Rincon I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005, 52:3413-3423. 10.1002/art.21397, 16255018.
35. Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Ishimura E, Inui K, Yutani Y, Miki T, Shoji T, Nishizawa Y. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002, 46:1489-1497. 10.1002/art.10269, 12115178.
36. Gerli R, Sherer Y, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci 2005, 1051:281-290. 10.1196/annals.1361.069, 16126969.
37. Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R. Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 2006, 33:244-247.
38. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000, 160:1085-1089. 10.1001/archinte.160.8.1085, 10789600.
39. Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS, Carroll D, Kitas GD. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology 2011, 50:2125-2139. 10.1093/rheumatology/ker275, 21926155.
40. Levick JR. An Introduction to Cardiovascular Physiology 2003, Kettering, UK: Oxford University Press.
41. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007, 46:1477-1482.
42. Ertl G, Hu K. Anti-ischemic potential of drugs related to the renin-angiotensin system. J Cardiovasc Pharmacol 2001, 37(Suppl 1):S11-S20.
43. Sandoo A, van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010, 4:302-312. 3040999, 21339899.
44. Orchard TJ, LLoyd CE, Maser RE, Kuller LH. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract 1996, 34(Suppl):S165-S171.
45. Taskiran M, Fritz-Hansen T, Rasmussen V, Larsson HB, Hilsted J. Decreased myocardial perfusion reserve in diabetic autonomic neuropathy. Diabetes 2002, 51:3306-3310. 10.2337/diabetes.51.11.3306, 12401723.
46. Aydemir M, Yazisiz V, Basarici I, Avci AB, Erbasan F, Belgi A, Terzioglu E. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 2010, 19:255-261. 10.1177/0961203309351540, 20015916.
47. Fisher JP, Paton JF. The sympathetic nervous system and blood pressure in humans: implications for hypertension. J Hum Hypertens 2012, 26:463-475. 10.1038/jhh.2011.66, 21734720.
48. Peters MJ, van Halm V, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA, Nurmohamed MT. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 2009, 61:1571-1579. 10.1002/art.24836, 19877093.
49. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, Protogerou A, Panoulas VF, Sandoo A, Tentolouris N, Mavrikakis M, Sfikakis PP. Atherosclerosis in rheumatoid arthritis versus diabetes. A comparative study. Arterioscler Thromb Vasc Biol 2009, 29:1702-1708. 10.1161/ATVBAHA.109.190108, 19608975.